Sofinnova Investments’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,806,529
Closed -$16.8M 69
2025
Q2
$16.8M Sell
1,806,529
-673,410
-27% -$5.88M 1.03% 30
2025
Q1
$24.2M Sell
2,479,939
-669,583
-21% -$8.29M 1.58% 19
2024
Q4
$38.1M Buy
3,149,522
+3,101,384
+6,443% +$37.7M 2.78% 11
2024
Q3
$528K Buy
+48,138
New +$489K 0.04% 59
2023
Q4
Sell
-503,844
Closed -$8.62M 74
2023
Q3
$8.62M Buy
503,844
+154,955
+44% +$3.04M 0.54% 39
2023
Q2
$8.1M Buy
+348,889
New +$6.82M 0.53% 33
2021
Q3
Sell
-71,661
Closed -$2.75M 83
2021
Q2
$2.75M Sell
71,661
-70,548
-50% -$2.41M 0.16% 59
2021
Q1
$4.34M Buy
142,209
+122,209
+611% +$4.58M 0.26% 51
2020
Q4
$763K Buy
+20,000
New +$833K 0.05% 65

Other funds holding REPL

Sofinnova Investments's REPL Position: Q3 2025 in Review

Sofinnova Investments sold out of Replimune Group (REPL) in Q3 2025, closing a stake of 1,806,529 shares — an estimated $16.8M sold.

Sofinnova Investments first reported a position in REPL in Q4 2020 and held it in 9 quarters. The position peaked at $38.1M in Q4 2024. 163 funds tracked by Wall St. Rank hold REPL as of Q3 2025.

  • Sofinnova Investments reported no remaining Replimune Group position as of Q3 2025 after selling out during the quarter.
  • Sofinnova Investments sold 1,806,529 Replimune Group shares in Q3 2025, an estimated $16.8M.
  • Sofinnova Investments first reported a position in Replimune Group in Q4 2020 and held it in 9 quarters.
  • Sofinnova Investments's Replimune Group position peaked at $38.1M in Q4 2024.
  • 163 funds tracked by Wall St. Rank held Replimune Group as of Q3 2025.

Based on Sofinnova Investments's 13F filing for Q3 2025, filed 14 Nov 2025.